Catalent Inc (CTLT) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Catalent Inc   (NYSE: CTLT)
 

Catalent Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTLT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 4.18 % 10.11 % 6.99 % 3.86 %
Q / Q Revenue Growth (Q3 MRQ) -21.37 % 3.78 % 2.75 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 4.71 % 2.85 % 5.76 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 0.94 % 2.45 % 1.76 % 1.09 %
Revenue 5 Year Average Growth 11.71 % 14.14 % 10.99 % 7.73 %


CTLT's Growth Comparisons in I. Quarter 2024




Although the Major Pharmaceutical Preparations industry saw advancing Revenue by 10.11%, Catalent Inc announced 4.18% year on year sales decline in the first quarter 2024, to $ 1.02 billions, and underperformed the 6.99% Revenue growth in the Healthcare sector. Above average sales gains in the Major Pharmaceutical Preparations industry and in the Healthcare sector, helped to elevate overall market growth to 3.86%.

Comparing company's Revenue to the fourth quarter results, sales were lower by -21.37% . On the annual basis, average annual sales growth for Catalent Inc is 11.71%, while S & P 500's including only Businesses with the first quarter 2024 results, average yearly sales growth is 7.73% over the past five years.

CTLT Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Excluding InterElimination
4.28 %
-
Biologics
2.9 %
-
PharmaConsumerHealth
5.43 %
-
Total Catalent InterEliminations
-
-
United States
2.02 %
-
Europe
20.8 %
-
International Other
-22.73 %
-
Biologics Manufacturing Commercial Product Supply
-13.48 %
-
Biologics Development Services
30.72 %
-
PharmaConsumerHealth Manufacturing Commercial Product Supply
8.38 %
-
PharmaConsumerHealth Development Services
0.5 %
-
Total Catalent before inter-revenue elimination Manufacturing Commercial Product Supply
-1.62 %
-
Total Catalent before inter-revenue elimination Development Services
14.21 %
-
Total
-76 %
-76.65 %


Growth Rates of CTLT's Income in the first quarter 2024


CTLT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 93.33 % 81.11 % 4.15 %
Sequential Operating Income Change (Q3 MRQ) - 42.86 % 32.85 % -2.56 %
Y / Y Operating Income Growth (Q3 TTM) - -23.14 % -1.21 % 8.98 %
Sequential Operating Income Growth (Q3 TTM) - 23.95 % 18.09 % 1.38 %
Operating Income 5 Year Avg. Change - 0.11 % -0.96 % 9 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 183.36 % 295.4 % -1.88 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) - 57.66 % 118 % -8.93 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 15.74 % 31.08 % 8.63 %
Sequential Income from Cont. Ops. Change (Q3 TTM) - 30.81 % 43.25 % -0.06 %
Income from Cont. Ops. 5 Year Avg. Change - -18.69 % -17.93 % 8.34 %

CTLT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - -40.91 % 6.9 % -6.54 %
Q / Q Net Income Growth (Q3 MRQ) - 55.9 % 132.21 % -6.96 %
Y / Y Net Income Change (Q3 TTM) - -28.25 % -3.83 % 5.08 %
Sequential Net Income Change (Q3 TTM) - -21.07 % 2.89 % -1.39 %
Net Income 5 Year Avg. Growth - 14.51 % 6.2 % 9.47 %

CTLT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 118.59 % 295.4 % -1.88 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) - 36.47 % 118 % -8.93 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -29.47 % -17.93 % 8.34 %



CTLT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - -54.42 % 6.9 % -6.54 %
Q / Q EPS Net Growth (Q3 MRQ) - 34.95 % 132.21 % -6.96 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - 14.51 % 6.2 % 9.47 %



Catalent Inc reported bottom-line of $ -0.71 in the first quarter, compare to $ -4.19 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -54.42%, while Healthcare sector increased by 6.9%, and overall market declined by -6.54%.

Comparing the company's EPS to the fourth quarter results, income per share were lower by -21.37% . On the annual basis, average annual income per share growth for Catalent Inc is 11.71%, while S & P 500's including only Businesses with the first quarter 2024 financial reports, average yearly income per share growth is 9.47% over the past five years.

CTLT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 45.39 % 50.19 % -41.6 %
Sequential Free Cash Flow Change (Q3 MRQ) -97.12 % 320.19 % 164.19 % -36.63 %
Y / Y Free Cash Flow Change (Q3 TTM) - 0.95 % 9.57 % 3.55 %
Sequential Free Cash Flow Change (Q3 TTM) - 12.36 % 12.44 % -10.73 %
Free Cash Flow 5 Year Avg. Change - 9.45 % 6.34 % 10.76 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - -
Sequential Net Cash Flow Change (Q3 MRQ) -63.78 % - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Sequential Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - -8.21 % -1.7 % -32.35 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -32.14 % 2.08 % 3.06 % 2.69 %
Sequential Capital Expenditures Change (Q3 MRQ) -24 % 10.94 % 6.53 % 2.4 %
Y / Y Capital Expenditures Change (Q3 TTM) -41.29 % 5.77 % 4.77 % 68.29 %
Sequential Capital Expenditures Change (Q3 TTM) -8.26 % 1.54 % 1.59 % -0.53 %
Capital Expenditures 5 Year Avg. Change 8.44 % 10.81 % 9 % 10.76 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.